Plunkett Research Online: Akebia Therapeutics Inc

AKEBIA THERAPEUTICS INC (AKBA:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Akebia Therapeutics, Inc. is a biopharmaceutical company that develops and commercializes therapeutics for patients with kidney disease. The firm has a commercial product and a late-stage product candidate: Auryxia (ferric citrate) and Vadadustat. Auryxia is approved and marketed in the U.S. for t.....



Akebia Therapeutics Inc
Ticker: AKBA
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 617 871-2098
Fax:
Address: 245 First Street
Suite 1100
Cambridge, MA 02142 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
Biopharmaceuticals
ContactsDescription

Jason AmelloCFO/Chief Accounting Officer/Senior VP/Treasurer
Adrian AdamsChairman of the Board/Director
See More
Akebia Therapeutics, Inc. is a biopharmaceutical company that develops and commercializes therapeutics for patients with kidney disease. The firm has a commercial product and a late-stage product candidate: Auryxia (ferric citrate) and Vadadustat. Auryxia is approved and marketed in the U.S. for t.....See More See More

Auditor: EY
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201920182017201620152014
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Auryxia
Vadadustat
Riona
Fexeric
Keryx Biopharmaceuticals Inc
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: